Company

Design Pharmaceuticals  brings together a unique multidisciplinary approach in bioinformatics, synthetic biology, genomics, immunology, along with deep pharma expertise. Together, the team is on a mission to harness  and expand nature’s chemistry to develop precise therapeutics for patients suffering from diseases lacking from satisfactory therapies.

Fred Dom Chairman VIEW MORE
Dirk Löffert, Ph.D. Founder and CEO VIEW MORE
Dirk Löffert, Ph.D. Board member VIEW MORE
Maxence Desjonquères Head of Business Development VIEW MORE
Xinhao Ye, Ph.D. Senior Director R&D Compound Development VIEW MORE
Guansheng Du, Ph.D. Director R&D Microfluidics VIEW MORE
Alex Dajkovic, Ph.D. Director R&D Microbiology & Assays VIEW MORE
John Hastewell Board Member VIEW MORE
Olivier Clyti Board Member VIEW MORE
Robert Nicol, Ph.D. Board Member VIEW MORE
Cosmas Giallourakis, MD VIEW MORE
Andrew Griffiths, Ph.D. VIEW MORE
Robert Nicol, Ph.D. VIEW MORE
Michael Jewett, Ph.D. VIEW MORE
Marnix Medema, Ph.D. VIEW MORE
Noah Palm, Ph.D. VIEW MORE
Dirk Loeffert, Ph.D. VIEW MORE